Overview Back Pain in Patients With Severe Osteoporosis Status: Completed Trial end date: 2010-12-01 Target enrollment: Participant gender: Summary The purpose of this study is to compare the effectiveness of teriparatide versus therapies that decrease bone loss to prevent new or worsening back pain in patients with osteoporosis seen in clinical practice. Details Lead Sponsor: Eli Lilly and CompanyTreatments: DiphosphonatesRaloxifene HydrochlorideTeriparatide